Cancer patients could get hit by higher costs under Obamacare.
Industry analysts are warning of thousands of dollars in new expenses for medications under Obamacare.
The higher costs could hit those suffering from chronic diseases such as cancer or rheumatoid arthritis and costs could vary depending on where you live.
Some states are allowing insurers to charge patients bigger drug co-pays to keep premiums down.
In California, patients would pay up to 30 percent of the cost. For a popular cancer drug called Gleevec, that could mean $2,000 or more a month, according to the Leukemia & Lymphoma Society.
New York's flat dollar copayments for medications would not exceed $70 a month, including "specialty" drugs.